About this policy
The comment period for the MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies DL38504 Local Coverage Determination (LCD) began on 5/7/19 and ended on 6/21/19. The comments below were received from the provider community. The notice period for MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies DL38504 begins on 12/26/19 and will become effective on 2/10/20.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.